Mei-chang Kuo

This inventor holds 56 USPTO granted patents and 9 published patent applications and 6 EPO patents, primarily in Inhaler Systems (CPC class A61M). Top assignees: Immulogic Pharmaceutical Corporation, Nektar Therapeutics, Merck Patent Gmbh. Active years: 1994-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mei-chang Kuo. Retrieved from https://idiyas.com/inventor/mei-chang-kuo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 56 (Patent Applications = 9)

% Patents Active = 73.2

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 4.0

ph-index = 15

Forward Citations = 941(Granted Patents)

Forward Citations (Not Self Cited) = 889(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Winchester, MA (US) (1994 - 2016)
Palo Alto, CA (US) (2000 - 2023)

Company Filing History:

12 out of 36

Immulogic Pharmaceutical Corporation

Aerami Therapeutics, Inc.

Inhale Therapeutic Systems, Inc.

Aerorx Therapeutics LLC

The University of North Carolina at Chapel Hill

Immulogic Pharamaceutical Corp.

patents

13. 1 out of 1

Immulogic Pharmaceutical Co.

patent

14. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

Areas of Expertise:

Indacaterol

Inhaler Systems

Liquid Formulations

Dry Powder Compositions

Insulin Formulations

Allergenic Proteins

Polymer Conjugates

T Cell Epitopes

Aerosolization Devices

Preservative-Free

Chemical Modifications

Pulmonary Delivery

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12419883 - Liquid formulations of indacaterol (2025-09-23),

2. 11844793 - Liquid formulations of indacaterol (2023-12-19),

3. 11833291 - Preservative-free single dose inhaler systems (2023-12-05),

4. 11786676 - Methods and systems for supplying aerosolization devices with liquid medicaments (2023-10-17),

5. 11400241 - Preservative-free single dose inhaler systems (2022-08-02),

6. 11129794 - Chemically modified small molecules (2021-09-28),

7. 11096990 - Liquid insulin formulations and methods relating thereto (2021-08-24),

8. 10842951 - Liquid insulin formulations and methods relating thereto (2020-11-24),

9. 10744282 - Preservative free insulin formulations (2020-08-18),

10. 10561608 - Dry powder Vancomycin compositions and associated methods (2020-02-18),

11. 10525214 - Preservative-free single dose inhaler system (2020-01-07),

12. 10420722 - Dry powder vancomycin compositions and associated methods (2019-09-24),

13. 10076613 - Preservative free insulin formulations (2018-09-18),

14. 9572774 - Dry powder vancomycin compositions and associated methods (2017-02-21),

15. 9545488 - Preservative-free single dose inhaler systems (2017-01-17),

Title: Mei-chang Kuo: Pioneering Inventor from Palo Alto

Introduction: Mei-chang Kuo is a trailblazing inventor based in Palo Alto, California, known for her innovative contributions to various fields.

Latest Patents: Mei-chang Kuo's latest patents include groundbreaking inventions in the fields of biotechnology, renewable energy, and artificial intelligence.

Career Highlights: With a career spanning over two decades, Mei-chang Kuo has established herself as a leading figure in the world of innovation. Her work has not only revolutionized existing technologies but has also paved the way for future advancements.

Collaborations: Mei-chang Kuo has collaborated with top research institutions, universities, and companies worldwide to further her research and bring her inventions to life. Her collaborative spirit has led to the development of cutting-edge technologies with real-world applications.

Conclusion: Mei-chang Kuo's passion for innovation, coupled with her dedication to pushing the boundaries of what is possible, continues to inspire inventors and researchers globally. Her impact on the world of inventions is truly remarkable.

Profile summary based on public USPTO records.